Exosomes carrying anti-miR-221 and gemcitabine curb pancreatic cancer growth
Pancreatic ductal adenocarcinoma remains one of the most formidable opponents in clinical oncology, a disease so aggressive and so resistant ...
Pancreatic ductal adenocarcinoma remains one of the most formidable opponents in clinical oncology, a disease so aggressive and so resistant ...
Oklahoma researchers have received a five-year, $2 million grant from the National Cancer Institute to investigate how pancreatic cancer alters ...
In a groundbreaking study published in the British Journal of Cancer, researchers from Fujita Health University have unveiled a novel ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine